ISSCR News
The ISSCR Files Amicus Brief Supporting FDA’s Authority to Regulate Unproven Stem Cell-Based Interventions
The International Society for Stem Cell Research (ISSCR) filed an amicus curiae brief today to support the U.S. government’s appeal in U.S. v. California Stem Cell Treatment Center, Inc., a case that ruled the Food and Drug Administration (FDA) cannot regulate dangerous unproven stem cell-based interventions.
ISSCR Members Advocate for Stem Cell Research at 2023 U.S. Congressional Advocacy Day
On 2 March, the International Society for Stem Cell Research (ISSCR) led a delegation of 20 members from across the U.S. to Capitol Hill to advocate for the importance of fetal tissue research, increased funding for the National Institutes of Health (NIH), and the potential of chimeric embryo research.
ISSCR Joins Coalition Letter to Support 5% Increase in NIH Funding for FY 2024
The ISSCR is among 373 members of the Ad Hoc Group for Medical Research who signed a joint letter in support robust funding for the National Institutes of Health (NIH). For fiscal year (FY) 2024, the Ad Hoc Group recommends at least $50.924 billion for NIH’s foundational work, a $3.465 billion increase over the comparable FY 2023 program level.
ISSCR Offers Recommendations on Risk Mitigation in Advancing Stem Cell Therapies
On 13 December 2022, ISSCR hosted its annual Liaison Meeting with the U.S. Food and Drug Administration. FDA professionals gathered virtually with ISSCR leaders to discuss advances in the development of stem cell therapies.
ISSCR Shares Concerns Regarding New Google Ads Policy
…the ISSCR is concerned that unscrupulous clinics may misuse the update to Google’s policy by promoting unproven therapies under the guise of distributing material that is “exclusively educational or informational in nature.” If so, this would harm consumers and public health.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .